Friday, April 19, 2019 5:38:20 PM
saving nickels saving dimes
working till the sun don't shine
looking forward to happier times
1963, Roy Orbison - On Blue Bayou
Recent HROW News
- Melt Pharmaceuticals Closes $24 Million Series B Preferred Stock Financing • Business Wire • 04/02/2024 12:16:00 PM
- JPMorgan boosts dividends, Chipotle unveils 50:1 stock split, and Latest News • IH Market News • 03/20/2024 11:15:48 AM
- Harrow Announces Fourth Quarter and Year-End 2023 Financial Results • Business Wire • 03/19/2024 09:45:00 PM
- US Index Futures Decline Ahead of Federal Reserve Meeting, Oil Prices Retreat • IH Market News • 03/19/2024 11:27:29 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2024 11:06:28 AM
- Harrow Will Release Fourth Quarter and Year-End 2023 Financial Results After Market Close on March 19, 2024 • Business Wire • 03/05/2024 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/22/2024 12:30:58 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/22/2024 12:29:43 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/15/2024 09:15:33 PM
- Harrow Licenses Canadian Rights to Apotex for Five Branded Ophthalmic Pharmaceutical Products • Business Wire • 02/15/2024 09:01:00 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/09/2024 09:05:33 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/08/2024 12:30:09 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/29/2024 09:30:18 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 01/29/2024 08:26:29 PM
- Harrow Announces New Appointments to its Board of Directors • Business Wire • 01/29/2024 12:00:00 PM
- Harrow Announces Availability of VEVYE® (Cyclosporine Ophthalmic Solution) 0.1%, the First and Only Cyclosporine-Based Product Indicated for Treating Both Signs and Symptoms of Dry Eye Disease • Business Wire • 01/11/2024 12:00:00 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 01/09/2024 03:16:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/03/2024 01:00:37 PM
- Melt Pharmaceuticals Provides Corporate Update • Business Wire • 01/03/2024 12:15:00 PM
- Harrow Partners with Leading Healthcare Market Access Technology Platforms • Business Wire • 01/03/2024 12:00:00 PM
- Harrow Completes Transfer of the TRIESENCE® New Drug Application • Business Wire • 11/29/2023 12:00:00 PM
- Harrow to Present at Two Investor Conferences in November • Business Wire • 11/20/2023 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/16/2023 09:05:31 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/15/2023 12:02:22 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2023 09:38:09 PM
Axis Technologies Group and Carbonis Forge Ahead with New Digital Carbon Credit Technology • AXTG • Apr 24, 2024 3:00 AM
North Bay Resources Announces Successful Equipment Test at Bishop Gold Mill, Inyo County, California • NBRI • Apr 23, 2024 9:41 AM
Epazz, Inc.: CryObo, Inc. solar Bitcoin operations will issue tokens • EPAZ • Apr 23, 2024 9:20 AM
Avant Technologies Launches Advanced AI Supercomputing Network and Expansive Data Solutions • AVAI • Apr 23, 2024 8:00 AM
BestGrowthStocks.com Issues Comprehensive Analysis of Triller Merger with AGBA Group Holding Limited • AGBA • Apr 22, 2024 1:00 PM
Cannabix Technologies to Present Marijuana Breathalyzer Technology at International Association for Chemical Testing (IACT) Conference in California • BLO • Apr 22, 2024 8:49 AM